Expression of hypoxia-inducing factor-1α and matrix metalloproteinase-9 in the recipient parasylvian cortical arteries with different hemodynamic sources in adult moyamoya disease

Objective In our latest research, we have demonstrated that the recipient parasylvian cortical arteries (PSCAs) with hemodynamic sources from the middle cerebral artery (M-PSCAs) has a higher risk of postoperative cerebral hyperperfusion (CHP) syndrome than those from non-M-PSCAs in adult moyamoya disease (MMD) patient. However, whether there are differences between M-PSCAs and non-M-PSCAs in vascular specimens characteristics has not been studied. In this study, we further investigate the vascular specimen of recipient PSCAs by histological and immunohistochemical methods. Methods 50 vascular specimens of recipient PSCAs were obtained from 50 adult MMD patients during the combined bypass surgeries in our departments of Zhongnan hospital. 4 recipient PSCAs samples were also obtained in the same way from the middle cerebral artery occlusion patients. The samples were received the pathological sectioning, hematoxylin and eosin staining, and immunohistochemistry, then the vascular wall thickness, matrix metalloproteinase-9 (MMP-9) and hypoxia-inducing factor-1α (HIF-1α) were analyzed. Results M-PSCAs adult MMD patients had a thinner intima than non-M-PSCAs in the recipient PSCAs specimens. In recipient non-M-PSCAs vascular specimens, the immunoreactivity indicating HIF-1α and matrix metalloproteinase-9 (MMP-9) was significantly higher than M-PSCAs groups. The logistic regression analyses showed that the M-PSCAs was an independent risk factor of postoperative cerebral hyperperfusion (CHP) syndrome (OR 6.235, 95% CI1.018-38.170, P = 0.048) in MMD. Conclusion Our results indicate that M-PSCAs adult MMD patients had thinner intima than non-MCAs adult MMD patients in the PSCAs. More importantly, HIF-1α and MMP-9 were overexpressed in non-M-PSCAs vascular specimens.

• Publication year

  2023

• Venue

  Frontiers in Surgery

• Publication date

  2023-03-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.3389/fsurg.2023.1080395PMID 36998597PMCID 10043197
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biological Functions and Regulatory Mechanisms of Hypoxia-Inducible Factor-1α in Ischemic Stroke

  2021cited by this paper
• MMP-9 as a Biomarker for Predicting Hemorrhagic Strokes in Moyamoya Disease

  2021cited by this paper
• Promote anti-inflammatory and angiogenesis using a hyaluronic acid-based hydrogel with miRNA-laden nanoparticles for chronic diabetic wound treatment.

  2020cited by this paper
• Piezo1 mediates angiogenesis through activation of MT1-MMP signaling.

  2019cited by this paper
• Melatonin protects blood-brain barrier integrity and permeability by inhibiting matrix metalloproteinase-9 via the NOTCH3/NF-κB pathway

  2019cited by this paper
• Hemodynamic analysis of the recipient parasylvian cortical arteries for predicting postoperative hyperperfusion during STA-MCA bypass in adult patients with moyamoya disease.

  2019influential reference
• Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.

  2018cited by this paper
• Intracranial Hemorrhage After Superficial Temporal Artery-Middle Cerebral Artery Direct Anastomosis for Adults with Moyamoya Disease.

  2018cited by this paper
• Meta-analysis of the surgical outcomes of symptomatic moyamoya disease in adults.

  2017cited by this paper
• Histopathological Characteristics of Distal Middle Cerebral Artery in Adult and Pediatric Patients with Moyamoya Disease

  2016cited by this paper
• Significance of the Hemorrhagic Site for Recurrent Bleeding: Prespecified Analysis in the Japan Adult Moyamoya Trial

  2016cited by this paper
• Moyamoya Disease: Treatment and Outcomes

  2016cited by this paper
• Moyamoya Disease: Epidemiology, Clinical Features, and Diagnosis

  2016cited by this paper
• Neuronal deficiency of HIF prolyl 4-hydroxylase 2 in mice improves ischemic stroke recovery in an HIF dependent manner.

  2016cited by this paper
• Histopathological features of middle cerebral artery and superficial temporal artery from patients with moyamoya disease and enlightenments on clinical treatment

  2016cited by this paper
• Quantitative analysis of early postoperative cerebral blood flow contributes to the prediction and diagnosis of cerebral hyperperfusion syndrome after revascularization surgery for moyamoya disease

  2015cited by this paper
• HIF-1α pathway: role, regulation and intervention for cancer therapy

  2015cited by this paper
• Hypoxia-inducible factor-1α and erythropoietin expression in the hippocampus of neonatal rats following hypoxia-ischemia.

  2014cited by this paper
• Hypoxia Inducible Factor-1: Its Potential Role In Cerebral Ischemia

  2012cited by this paper
• Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis).

  2012cited by this paper
• Expression profiling of ETS and MMP factors in VEGF‐activated endothelial cells: Role of MMP‐10 in VEGF‐induced angiogenesis

  2010cited by this paper
• Delayed intracerebral hemorrhage after superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya disease: possible involvement of cerebral hyperperfusion and increased vascular permeability.

  2009cited by this paper
• Increased expression of serum Matrix Metalloproteinase-9 in patients with moyamoya disease.

  2009cited by this paper
• Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease

  2009cited by this paper
• Progress in matrix metalloproteinase research.

  2008cited by this paper
• Brain protection by erythropoietin: a manifold task.

  2008cited by this paper
• Pathological and immunohistochemical findings of an autopsy case of adult moyamoya disease

  2004cited by this paper
• Expression of transforming growth factor-b1 and hypoxia-inducible factor-1a in an experimental model of kidney transplantation.

  2003cited by this paper
• Activation of Hypoxia-Inducible Factor-1 in the Rat Cerebral Cortex after Transient Global Ischemia: Potential Role of Insulin-Like Growth Factor-1

  2002cited by this paper
• Physiologically low oxygen concentrations determined in fetal skin regulate hypoxia‐inducible factor 1 and transforming growth factor β3

  2002cited by this paper
• Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain.

  1969cited by this paper

• No citing papers are available for this paper.